Cargando…
Cytotoxic Effects of Nanoliposomal Cisplatin and Diallyl Disulfide on Breast Cancer and Lung Cancer Cell Lines
Dual drug delivery has become the choice of interest nowadays due to its increased therapeutic efficacy in targeting the tumor site precisely. As quoted in recent literature, it has been known to treat several cancers with an acute course of action. Even so, its use is restricted due to the drug’s l...
Autores principales: | Gunasekaran, Kaavya, Vasamsetti, Bala Murali Krishna, Thangavelu, Priyadharshini, Natesan, Karthi, Mujyambere, Bonaventure, Sundaram, Viswanathan, Jayaraj, Rama, Kim, Yeon-Jun, Samiappan, Suja, Choi, Jae-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136257/ https://www.ncbi.nlm.nih.gov/pubmed/37189638 http://dx.doi.org/10.3390/biomedicines11041021 |
Ejemplares similares
-
Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer
por: Malla, RamaRao, et al.
Publicado: (2022) -
Design, synthesis and analysis of charged RGD derivatives
por: Mujyambere, Bonaventure, et al.
Publicado: (2023) -
Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy
por: Jayaraj, Rama, et al.
Publicado: (2019) -
Induction of apoptosis with diallyl disulfide in AGS gastric cancer cell line
por: Lee, Jeong-Eun, et al.
Publicado: (2011) -
Tristetraprolin: A novel target of diallyl disulfide that inhibits the progression of breast cancer
por: Xiong, Ting, et al.
Publicado: (2018)